Tag Archives: NASDAQ:HQY

Healthequity (HQY) Gets a Hold Rating from BTIG

In a report released yesterday, David Larsen from BTIG maintained a Hold rating on Healthequity (HQY – Research Report). The company’s shares closed last Monday at $82.31. According to TipRanks.com, Larsen is a 2-star analyst with an average return of

Analysts Offer Insights on Financial Companies: and Healthequity (NASDAQ: HQY)

Analysts fell to the sidelines weighing in on and Healthequity (HQY – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks. Healthequity (HQY) Robert W. Baird analyst Mark Marcon maintained a Hold

A Director at Healthequity is Exercising Options

Today it was reported that a Director at Healthequity (HQY – Research Report), Frank Corvino, exercised options to sell 7,403 HQY shares at $14.00 a share, for a total transaction value of $561K. Following Frank Corvino’s last HQY Sell transaction

Raymond James Sticks to Their Buy Rating for Healthequity (HQY)

Raymond James analyst Charles Peters maintained a Buy rating on Healthequity (HQY – Research Report) yesterday. The company’s shares closed last Tuesday at $59.52. According to TipRanks.com, Peters is a 5-star analyst with an average return of 9.4% and a

Deutsche Bank Sticks to Its Buy Rating for Healthequity (HQY)

In a report released today, George Hill from Deutsche Bank maintained a Buy rating on Healthequity (HQY – Research Report), with a price target of $57.00. The company’s shares closed last Monday at $42.02, close to its 52-week low of

Healthequity (HQY) Receives a Rating Update from a Top Analyst

Robert W. Baird analyst Mark Marcon maintained a Hold rating on Healthequity (HQY – Research Report) today and set a price target of $47.00. The company’s shares closed last Monday at $41.34, close to its 52-week low of $36.48. According